| |
| |
|
| Insider
Information: |
Uger Robert |
| Relationship: |
Chief Scientific Officer |
| City: |
Mississauga |
| State: |
A6 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trillium Therapeutics Inc |
TRIL |
Chief Scientific Officer |
2021-07-07 |
0 |
2021-01-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-07-07 |
4 |
AS |
$9.00 |
$32,814 |
D/D |
(3,646) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-07-07 |
4 |
OE |
$0.30 |
$1,108 |
D/D |
3,646 |
3,646 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-06-07 |
4 |
AS |
$8.27 |
$30,152 |
D/D |
(3,646) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-06-07 |
4 |
OE |
$0.32 |
$1,148 |
D/D |
3,646 |
3,646 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-05-07 |
4 |
OE |
$0.31 |
$1,141 |
D/D |
3,646 |
3,646 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-05-07 |
4 |
AS |
$9.30 |
$33,908 |
D/D |
(3,646) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-04-07 |
4 |
AS |
$10.82 |
$39,450 |
D/D |
(3,646) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-04-07 |
4 |
OE |
$0.30 |
$1,098 |
D/D |
3,646 |
3,646 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-03-12 |
4 |
AS |
$11.97 |
$34,916 |
D/D |
(2,917) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-03-12 |
4 |
OE |
$3.39 |
$9,896 |
D/D |
2,917 |
2,917 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-03-08 |
4 |
AS |
$10.11 |
$36,861 |
D/D |
(3,646) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-03-08 |
4 |
OE |
$0.30 |
$1,093 |
D/D |
3,646 |
3,646 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-02-09 |
4 |
AS |
$14.12 |
$8,248 |
D/D |
(584) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-02-09 |
4 |
OE |
$9.62 |
$5,619 |
D/D |
584 |
584 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-02-08 |
4 |
AS |
$12.65 |
$83,022 |
D/D |
(6,563) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-02-08 |
4 |
OE |
$0.30 |
$10,751 |
D/D |
6,563 |
6,563 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-11 |
4 |
OE |
$9.57 |
$5,587 |
D/D |
584 |
584 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-11 |
4 |
AS |
$15.20 |
$8,879 |
D/D |
(584) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-08 |
4 |
AS |
$15.51 |
$133,806 |
D/D |
(8,517) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-08 |
4 |
OE |
$3.33 |
$71,365 |
D/D |
8,517 |
2,917 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-07 |
4 |
AS |
$14.75 |
$53,782 |
D/D |
(3,646) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-07 |
4 |
OE |
$0.30 |
$1,089 |
D/D |
3,646 |
3,646 |
0 |
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
